Health Research

Research identifies RNA structures linked to Parkinson’s

HQ Team November 20, 2024: A team of researchers from Kumamoto University has found that unique RNA structures known as G-quadruplexes (G4s) facilitate.

Read More
Drugs Medical Pharma

FDA approves AbbVie’s new drug for advanced Parkinson’s disease

HQ Team October 19, 2024: The U.S. Food and Drug Administration (FDA) has approved AbbVei’s drug Vyalev for the treatment of advanced Parkinson’s.

Read More
Drugs Health Pharma

GI tract damage may increase the risk of Parkinson’s disease by 76% 

People with a history of damage to the lining of their upper gastrointestinal (GI) tract are at a 76% higher risk of developing.

Read More
Drugs Health Pharma

Cigarette smoking may help fight Parkinson’s disease: Harvard research

Smoking cigarettes may protect humans from neurodegeneration and prevent the accumulation of a key Parkinson’s-associated protein in the brain, new research on mice.

Read More
Drugs Health Pharma

Biogen, Sage halt tremor trial after ‘disappointing’ oral drug results

An oral investigational drug jointly developed by Biogen Inc., and Sage Therapeutics Inc., failed to stop essential tremors in patients, forcing the companies.

Read More
Drugs Health Pharma

Scotland’s medical university team cures Parkinson’s patient’s tremors

Scotland's researchers and doctors have performed a non-invasive operation on a patient with Parkinson’s disease using the country’s first ultrasound thalamotomy that allowed.

Read More
Climate Health Opinion Pharma

Opinion: Pesticide exposure and its link to Parkinson’s disease 

Understanding the genetic and environmental factors contributing to the development of Parkinson’s is crucial for improving prevention and treatment strategies. 

Read More
Drugs Health Pharma

Simple skin biopsy test can detect Parkinson’s disease: Harvard study

HQ Team March 21, 2024: An abnormal protein called phosphorylated α-synuclein present in the nerve fibres in the skin — the pathological hallmark.

Read More
Drugs Health Pharma

AbbVie to acquire Cerevel for $8.7b to bolster neurological treatments

HQ Team December 7, 2023: AbbVie Inc., will buy Cerevel Therapeutics, developing drugs for neuroscience diseases, for $8.7 billion in a bid to.

Read More
Drugs Health Pharma

Swedish researchers identify new biomarker to detect Parkinson’s disease

HQ Team September 26, 2023: Researchers at Sweden’s Lund University have identified a new biomarker to detect Parkinson’s disease before a person develops.

Read More